Libaccord

Libaccord Overview

Libaccord is the developer of an innovative device for treating ventricular and atrial arrhythmias using super-cooled liquid nitrogen. Based on the deepest possible ablation (transmural), the companys solution uses the novel clinical approach of scar homogenization to reduce procedure time and includes built-in ablation depth feedback to ensure performance and safety.

Latest News

Jan 10, 2022 · www.haaretz.co.il

growth-positive

עם היד (הטכנולוגית) על הדופק

The article discusses the issue of heart rhythm disorders, which affects millions of people worldwide. It highlights the work of Dr. Gregory Golobchiner, who is involved with two startups, CardioKol and LibAccord. CardioKol has developed a technology that uses an app to detect atrial fibrillation based on a persons voice. LibAccord, on the other hand, is developing a technique for ablating heart rhythm disorders. Both technologies aim to improve early detection and treatment of heart rhythm disorders.

CustomersPartnersInvestment

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Haifa, Israel

Photos & Videos

No files yet

Libaccord Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info